J. D. Grabenstein and K. P. Klugman, A century of pneumococcal vaccination research in humans

, Clin Microbiol Infect, vol.18, issue.5, pp.15-24, 2012.

R. Austrian, A brief history of pneumococcal vaccines, Drugs Aging, vol.15, pp.1-10, 1999.

P. Kazanjian, Changing interest among physicians toward pneumococcal vaccination throughout the twentieth century, J Hist Med Allied Sci, vol.59, issue.4, pp.555-87, 2004.

T. Van-der-poll, S. M. Opal, and . Pathogenesis, Lancet, vol.374, pp.1543-56, 2009.

J. P. Lynch, . Iii, and G. G. Zhanel, Streptococcus pneumoniae: epidemiology, risk factors, and strategies forprevention. Seminars in respiratory and critical care medecine, vol.30, pp.189-209, 2009.

X. Duval, S. Tubiana, E. Varon, M. Revest, I. Gorenne et al., Streptococcus pneumoniae meningitis morbidity and mortality: results from the French national meningitis cohort(COMBAT) 2016

, Haut Conseil de la santé publique, Avis relatif aux recommandations vaccinales contre les infections à pneumocoque pour les adultes 10 mars, 2017.

F. Epibac and . Métropolitaine-données, Incidence redressée pour défaut de couverture et corrigée pour sous notifications, 2014.

, Epibac 2014 et étude, surveillance des infections invasives à pneumocoques chez l'adulte, SIIPA 2012-2015, données ORP-CNRP-Spilf-ANSP non publiées, estimation ANSP

, Immunological Memory, vol.46, pp.1015-1023, 2008.

L. A. Jackson, A. Gurtman, and M. Van-cleeff, Immunogenicity and safety of a 13 valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults, Vaccine, vol.31, pp.3577-84, 2011.

R. Lazarus, E. Clutterbuck, L. M. Yu, J. Bowman, and E. A. Bateman, A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination in adults, Clin Infect Dis, vol.52, pp.736-778, 2011.

L. A. Jackson, A. Gurtman, and M. Van-cleeff, Immunogenicity and safety of a 13 valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine, Vaccine, vol.31, pp.3585-93, 2013.

C. H. Van-werkhoven, S. M. Huijts, M. Belkenhaas, D. E. Grobbee, and M. Bonten, The impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly, Clin Infect Dis, vol.61, pp.1835-1843, 2015.

S. Patterson, C. Webber, M. Patton, W. Drews, and S. M. Huijts, Post hoc assessment of duration of protection in CAPITA, Trials in Vaccinology, vol.5, pp.92-98, 2016.

S. A. Moberley, J. Holden, D. P. Tatham, and R. M. Andrews, Vaccines for preventing pneumococcal infection in adults (review).The Cochrane Collaboration. The Cochrane Library, p.422, 2008.

S. A. Moberley, J. Holden, D. P. Tatham, and R. M. Andrew, Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev, p.422, 2013.

J. A. Walters, J. N. Tang, P. Poole, and R. Wood-baker, Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, vol.001390, 2017.

G. Falkenhorst, C. Remschmidt, T. Harder, E. Hummers-pradier, O. Wichmann et al., Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PP23) against pneumococcal disease in the elderly : systematic review and meta-analysis, PLoS ONE 2017, vol.12, issue.1, p.169368

N. J. Andrews, P. A. Waight, R. C. George, M. C. Stack, and E. Miller, Impact and effectiveness of 23-valent pneumococcal vaccines against invasive pneumococcal disease in the elderly in England and Wales, Vaccine, vol.30, pp.6802-6810, 2012.

M. Suzuki, B. Gopal, T. Ishifuji, and M. Yasunami, Serotype specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older : a multicentre, prospective, test-negative design study, Lancet Infect Dis, vol.17, issue.3, pp.313-321, 2017.

R. N. Greenberg, A. Gurtman, and M. Van-cleef, Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age, Vaccine, vol.32, pp.2364-74, 2014.

, Méthode générale de la cartographie des pathologies, version G5 (années, 2012.

, Mise à jour : 8 mars, Caisse Nationale d'Assurance Maladie (CNAM), 2018.

. Stratégie, des Etudes et des Statistiques -Département des Etudes sur les Pathologies et les Patients

C. Vanhaecke-collard, N. J. Mahmoudi, R. Geriatr-psychol-neuropsychiatr, and . Vieil,

, Influenza and pneumococcal vaccine coverage among patients admitted to an acute geriatric unit, vol.11, pp.7-14

G. Gavazzi, B. Wazieres, B. Lejeune, and M. Rothan-tondeur, Gerontology, vol.53, issue.6, pp.382-389, 2007.

, Influenza and pneumococcal vaccine coverages in geriatric health care settings in france, Epub, 2007.

K. Risso, A. Naqvi, S. Pillet, A. Leplatois, and C. Pulcini, Med Mal Infect, vol.40, issue.6, pp.341-347, 2010.

C. Richard, L. Garlantezec, P. Lamand, V. Rasamijao, V. Rapp et al., Ann Pharm Fr, 2016.

, Antipneumococcal vaccine coverage for hospitalized risk patients: Assessment and suggestions for improvements, vol.74, pp.244-51, 2015.

T. Goulenok, D. Chopin, D. Lastours, V. Zarrouk, V. Lepeule et al., Influenzae and pneumococcal vaccination rate in an internal medicine ward, Rev Med Interne, vol.39, issue.6, pp.386-392, 2018.

F. Vandenbos, J. Gal, and B. Radicchi, Vaccination coverage against influenza and pneumococcus for patients admitted to a pulmonary care service, vol.30, pp.746-51, 2013.

E. Rouveix, G. Cherni, D. Dupont, C. Beauchet, A. et al.,

, Med Mal Infect, vol.43, issue.1, pp.22-29, 2013.

, Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in

. France, L'intergroupe Société de pathologie infectieuse de langue française/Société de gériatrie et gérontologie clinique (SPILF/SGGC)

A. C. O'halloran, P. J. Lu, and P. T. Vaccine, Pneumococcal vaccination coverage among persons ?65 years--United States, vol.33, pp.5503-5506, 2013.

A. Vila-corcoles, O. Ochoa-gondar, I. Hospital, C. De-diego, E. Satué et al., Hum Vaccin Immunother, vol.12, issue.11, pp.2953-2958, 2016.

, Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia, Epub, 2016.

, La Vaccination antipnumococcique chez l'adulte en région PACA-Corse: étude des prescriptions et du suivi des recommandations. p23-26 Dr Jonathan Lyon-Bilger, sous la direction du Dr Sébastien Adnot, 2013.

J. Batah, E. Varon, C. Cnrp, and . Nationnal-de-référence-des-pneumoccoques, , p.6, 2016.

, La Vaccination antipneumococcique chez l'adulte en région PACA-Corse: étude des prescriptions et du suivi des recommandations. p33-36 Dr Jonathan Lyon-Bilger, sous la direction du Dr Sébastien Adnot, 2013.

, Direction Générale de la Santé (Ministère des Affaires sociales, de la Santé et de la Solidarité), Calendrier des vaccinations et recommandations vaccinales 2017, pp.23-24